OVERVIEW
A report by Global Market Studies has shown a CAGR of 28.1% for the Digital Therapeutics Market which is expected to expand to a value of USD 43.62 billion by 2028 from USD 12.6 billion in 2023.Â
The Digital Therapeutics market refers to the use of technology to treat medical conditions and improve patient outcomes. Digital therapeutics (DTx) solutions are usually software-based interventions that provide evidence-based therapeutic interventions to patients.
DTx solutions can be used to treat a wide range of medical conditions, including diabetes, cardiovascular diseases, respiratory disorders and mental health conditions. These treatments are applied through a variety of platforms including mobile apps, wearables and online portals.
TABLE OF CONTENT
1 Global Digital Therapeutics MarketÂ
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Digital Therapeutics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Digital Therapeutics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Digital Therapeutics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Digital Therapeutics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Digital Therapeutics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Digital Therapeutics Market – By Application (Market Size – & million/billion)
8.1 Preventive
8.2 Treatment/Care
9 Global Digital Therapeutics Market – By Sales Channel
9.1 B2C
9.2 B2B
10 Global Digital Therapeutics Market – By Geography (Market Size – & million/billion)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 U.K
10.3.2 Germany
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Rest of the World
10.5.1 South America
10.5.2 Middle East
10.5.3 Africa
11 Global Digital Therapeutics Market – Entropy
11.1 New product launches
11.2 M&A’s, collaborations, JVs and partnerships
12 Global Digital Therapeutics Market Company Profile (Key Players)
12.1 Market Share, Company Revenue, Products, M&A, Developments
12.2 Proteus Digital Health, Inc.
12.3 Omada Health, Inc.
12.4 Welldoc, Inc.
12.5 2morrow Inc.
12.6 Canary Health Inc.
12.7 Mango Health Inc.
12.8 Livongo Health
12.9 Ginger.Io, Inc.
12.10 Propeller Health
12.11 Noom Inc.
12.12 Company 11 & more
13 Global Digital Therapeutics Market – Appendix
13.1 Sources
13.2 Abbreviations
